238 | EPCORITAMAB PLUS LENALIDOMIDE AND RITUXIMAB ACHIEVES HIGH RESPONSE RATES AND SURVIVAL BENEFITS COMPARED WITH USUAL CARE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	L. Falchi, M. Hutchings, D. Tybor, J. Yu, A. Alshreef, A. Wang, Z. Ding, A. Mutebi, P. Patah, N. Kishore, A. Rana, E. Favaro, K. Linton
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Hematological Oncology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet